AGP Picks
View all

Reporting on science and technology news in Montana

Provided by AGP

Sci-Tech Montana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Montana.

Press releases published on May 15, 2026

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
Bond Provides Business Update and Reports 2026 First Quarter Financial Results
BioCardia Reports First Quarter 2026 Business Highlights and Financial Results
Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)
GT Biopharma Reports First Quarter 2026 Financial Results
ELECTRA AI and Iron Horse Acquisition II Corp. (Nasdaq: IRHO) Announce Filing of Registration Statement on Form S-4 with the SEC in Connection with their Proposed Business Combination
Xpanner Secures $18 Million Series B Bridge Round to Scale AI-Powered Automation in Construction
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
Profusa Announces Listing Transfer to The Nasdaq Capital Market
JOYY to Announce First Quarter 2026 Financial Results on May 25, 2026
Quantum Cyber Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, and Quantum Technology Sectors
Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:

Sign up for:

Sci-Tech Montana

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.